Cubist Systematic Strategies’s Anika Therapeutics ANIK Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	$352K	Buy	+37,447	New	+$358K	0.01%	2437
2025 Q1	–	Sell	-11,990	Closed	-$197K	–	2851
2024 Q4	$197K	Buy	11,990 +4,682	+64%	+$92.3K	﹤0.01%	2575
2024 Q3	$181K	Sell	7,308 -3,970	-35%	-$103K	﹤0.01%	2596
2024 Q2	$286K	Sell	11,278 -11,420	-50%	-$296K	﹤0.01%	2376
2024 Q1	$577K	Sell	22,698 -16,820	-43%	-$407K	0.01%	2535
2023 Q4	$895K	Sell	39,518 -38,294	-49%	-$792K	0.01%	2130
2023 Q3	$1.45M	Buy	+77,812	New	+$1.61M	0.02%	1605
2022 Q4	–	Sell	-10,900	Closed	-$259K	–	4217
2022 Q3	$259K	Sell	10,900 -4,281	-28%	-$98.5K	﹤0.01%	3602
2022 Q2	$339K	Buy	+15,181	New	+$339K	﹤0.01%	3348
2022 Q1	–	Sell	-4,527	Closed	-$162K	–	3536
2021 Q4	$162K	Buy	+4,527	New	+$181K	﹤0.01%	3093
2020 Q3	–	Sell	-7,783	Closed	-$294K	–	2475
2020 Q2	$294K	Sell	7,783 -13,152	-63%	-$433K	0.01%	1854
2020 Q1	$605K	Sell	20,935 -169	-0.8%	-$6.84K	0.02%	1134
2019 Q4	$1.09M	Buy	21,104 +12,425	+143%	+$722K	0.02%	1103
2019 Q3	$476K	Sell	8,679 -4,891	-36%	-$251K	0.01%	1310
2019 Q2	$551K	Buy	+13,570	New	+$495K	0.01%	1415
2018 Q4	–	Sell	-6,267	Closed	-$264K	–	2038
2018 Q3	$264K	Buy	+6,267	New	+$248K	0.01%	1256

Other funds holding ANIK